1. Botulinum Toxin Type A Injections for Treating Neurogenic Detrusor Overactivity Combined With Low-Compliance Bladder in Patients With Spinal Cord Lesions 
Jakkrit Klaphajone, MD, Wasuwat Kitisomprayoonkul, MD, Supon Sriplakit, MD 
Archives of Physical Medicine and Rehabilitation 
Volume 86, Issue 11, Pages (November 2005)
DOI: /j.apmr
Copyright © 2005 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

2. Fig 1
Mean bladder compliance at the baseline, 6-, 16-, and 36-week visits. Error bars indicate SD. *P<.05 relative to baseline.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2005 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

3. Fig 2
Mean volume for maximum bladder capacity at the baseline, 6-, 16-, and 36-week visits. Error bars indicate SD. *P<.05 relative to baseline.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2005 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

4. Fig 3
Mean volume at first reflex at the baseline, 6-, 16-, and 36-week visits. Error bars indicate SD. *P<.05 relative to baseline.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2005 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

5. Fig 4
Mean maximal detrusor contraction pressure at the baseline, 6-, 16-, and 36-week visits. Error bars indicate SD. *P<.05 relative to baseline.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2005 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions